Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Tris Pharma
Biotech
Tris shows its opioid alternative is less likely to be abused
Having shown its opioid alternative can reduce pain, Tris is back with another slice of clinical data to show the drug is less likely to be abused.
James Waldron
Jan 28, 2025 10:53am
Tris' opioid alternative reduces post-surgery pain in phase 3
Jan 22, 2025 8:30am
Cerevel swaps CEO—Chutes & Ladders
May 5, 2023 9:30am
Back-to-back FDA rejections leave Vernalis reeling
Aug 7, 2017 7:49am
Vernalis falls after FDA knocks back cough-cold drug filing
Apr 21, 2017 6:09am